RATE THIS ARTICLE
1 -Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19(9):2542–2554.
2 -Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD. February 22, 2013.
3 -Swegle, JM. Management of Common Opioid-Induced Adverse Effects. Am Fam Physician. 2006 Oct 15;74(8):1347-1354.
4 -Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-34.
5 -Dovjak P. Tools in polypharmacy: current evidence from observational and controlled studies. Z Gerontol Geriat. 2012;45:468-472.
6 -Sites BD, Beach ML, Davis MA. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med. 2014;39(1):6-12.
7 -Wan Y, Corman S, Gao X, et al. Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain. Am Health Drug Benefits. 2015;8:93-102.
8 -Deyo, RA, Smith DHM, Johnson ES, et al. Prescription Opioids for Back Pain and Use of Medications for Erectile Dysfunction. Spine. 2013; 38(11): 909-915. doi: 10.1097/BRS.0b013e3182830482